slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,369
Current window 33,901-33,930
Pages 1,379
Rows per page 30
Component
33,901-33,930 of 41,369
33
Includes a biological pathway diagram and a honeycomb diagram for indications.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
37
The chart is a waterfall plot showing drug response scores across many patient samples, color-coded by diagnosis.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
38
The slide uses a heatmap to correlate '617 sensitivity with synergy outcomes for three different drug combinations.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
46
The slide uses a human anatomy diagram to map specific disease indications to their respective patient counts.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
49
The slide uses a process flow diagram to explain the therapeutic mechanism and competitive advantage of the '539 molecule.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
50
Exscientia | Investor Presentation Deck | 76 slidesExscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
64
Exscientia | Investor Presentation Deck | 76 slidesExscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
08
The slide uses a human anatomy diagram to map specific patient counts to disease locations.Exscientia | Results Presentation Deck | 24 slides · Exscientia
Conference presentation Investor relations Beat · EvidenceLoop · Logic Chain1 hit
06
Uses authority-citation framework via CEO quotes to validate the problem statement.FiscalNote | Investor Presentation Deck | 33 slides · FiscalNote
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
The slide uses a visual metaphor of a pyramid or funnel originating from a government building icon to represent market expansion.FiscalNote | Investor Presentation Deck | 33 slides · FiscalNote
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
11
FiscalNote | Investor Presentation Deck | 33 slidesFiscalNote | Investor Presentation Deck | 33 slides · FiscalNote
Pitch deck Investor relations 1 hit
12
The slide uses a process flow diagram to illustrate the company's proprietary data infrastructure.FiscalNote | Investor Presentation Deck | 33 slides · FiscalNote
Pitch deck Investor relations 1 hit
17
The slide uses a timeline-based expansion journey on the right and a bar chart for ARR growth on the bottom left.FiscalNote | Investor Presentation Deck | 33 slides · FiscalNote
Pitch deck Investor relations 1 hit
19
The slide uses a combination of a text-based timeline for the expansion journey and a bar chart for ARR growth.FiscalNote | Investor Presentation Deck | 33 slides · FiscalNote
Pitch deck Investor relations 1 hit
04
Uses an analogy to establish market positioning.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
12
The chart uses a trend line to emphasize the growth trajectory.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
14
Freightos | Investor Presentation Deck | 34 slidesFreightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
15
Includes logos for CME Group and SGX as partners/integrators.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
17
The chart tracks the Q3 2021 cohort's transaction volume as a percentage of their initial booking volume in the first quarter.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
04
The slide uses a linear process flow to highlight competitive differentiation.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
05
The slide uses a Gantt-style visualization to represent drug development stages.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
09
Includes a visual case study (Subject #4) showing PET scan response.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
11
The slide illustrates the transition from a 177Lu-based molecule (IPN-1087) to a 225Ac-based molecule (FPI-2059) to improve efficacy.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Market Opportunity1 hit
15
The slide uses a PET scan image to demonstrate selective tumor uptake versus normal tissue, and a table to quantify market opportunity by tumor type.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
18
The slide highlights a specific program (Program 1) involving dual targeting of EGFR and cMET using Fusion's FastClear linker technology.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
19
The slide uses a combination of a process diagram for the in vivo study and a line chart to show efficacy results.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
24
The slide uses medical imaging (SPECT/CT) to visually demonstrate the efficacy of a pre-dose strategy in optimizing pharmacokinetics.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
25
The slide presents clinical trial data comparing pharmacokinetics and safety (thrombocytopenia) profiles.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
28
Includes a PET/CT scan image as a case study example.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
13
The slide uses a two-column layout with text on the left and a brand-reinforcing photo on the right.Hagerty | Investor Presentation Deck | 24 slides · Hagerty
Pitch deck Investor relations 1 hit